J Frontier Co., Ltd. (2934) AI Stock Analysis

• Market Cap: ¥6.69B
• Dividend Yield: N/A
• Average Volume (3M): 40.58K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.03
• Revenue Growth: 11.40%
• EPS Growth: N/A
• Country: JP
• Employees: 315
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -29.46
• Shares Outstanding: 5,333,465
• 10 Day Avg. Volume: 58,880
• 30 Day Avg. Volume: 40,583
• PEG Ratio: -0.89
• Price to Book (P/B): 5.74
• Price to Sales (P/S): 0.38
• P/FCF Ratio: 18.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: ¥1,205.00 ▼(-9.13% Downside)
• Action: Reiterated Date: 12/03/25
• Date: Action: Reiterated 12/03/25

The overall stock score is primarily impacted by the company's financial performance challenges and bearish technical indicators. The high P/E ratio suggests overvaluation, further contributing to a low score. The lack of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Stable gross profit margin

Relatively stable gross margins indicate the company preserves core product/service economics versus volatile net results. That resilience supports durable cash generation at the gross level, helps absorb SG&A swings and provides a base for restoring operating margins over the medium term.

Improving free cash flow

An improving free cash flow trend enhances the firm's ability to fund operations, invest selectively, and service debt without relying solely on external financing. Sustained FCF growth provides strategic flexibility to repair the balance sheet and support long-term initiatives.

Stable equity ratio

A relatively stable equity ratio suggests the company has maintained a core capital base through recent volatility. That stability underpins creditor confidence and gives management room to execute deleveraging or targeted investments, supporting medium-term financial resilience.

Negative Factors

High leverage

A high debt-to-equity ratio raises refinancing and interest-service risk, particularly given uneven earnings. Elevated leverage constrains capital allocation, increases vulnerability to macro shocks, and amplifies downside if revenue or margins deteriorate over the coming months.

Inconsistent revenue growth

Irregular top-line performance and a recent decline undermine predictability of cash flow and scale economics. Without steady revenue expansion, margin recovery and debt reduction are more difficult, limiting the company's ability to build sustainable profitability in the medium term.

Weak operating cash conversion

Negative operating cash flow relative to net income signals earnings quality issues and a gap between reported profit and cash generation. This reduces internal funding for capex and debt service, potentially forcing reliance on external financing and weakening long-term financial flexibility.

J Frontier Co., Ltd. Business Overview & Revenue Model

Company Description

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.

How the Company Makes Money

null

J Frontier Co., Ltd. Financial Statement Overview

Summary

J Frontier Co., Ltd. faces challenges in maintaining consistent revenue growth and profitability, with high leverage posing potential risks. While there are signs of improvement in cash flow, the company needs to focus on stabilizing its financial performance and managing debt levels to enhance long-term sustainability.

Income Statement

The income statement shows a mixed performance. Gross profit margin has been relatively stable, but the net profit margin has fluctuated significantly, with recent improvements. Revenue growth has been inconsistent, with a notable decline in the latest period. EBIT and EBITDA margins have also been volatile, indicating challenges in maintaining operational efficiency.

Balance Sheet

The balance sheet indicates a high debt-to-equity ratio, suggesting potential leverage risks. However, the equity ratio has been relatively stable. Return on equity has been negative in recent periods, reflecting profitability challenges. The company needs to manage its debt levels to improve financial stability.

Cash Flow

Cash flow analysis shows improvement in free cash flow growth, but operating cash flow has been inconsistent. The operating cash flow to net income ratio has been negative, indicating cash flow challenges. However, the free cash flow to net income ratio suggests some ability to generate cash relative to net income.

Breakdown	May 2024	May 2023	May 2022	May 2022	May 2021
Income Statement
Total Revenue	21.50B	17.71B	16.84B	11.88B	8.49B
Gross Profit	9.57B	8.33B	7.12B	5.40B	6.63B
EBITDA	914.54M	-1.22B	-1.54B	760.66M	706.10M
Net Income	87.57M	-2.09B	-1.90B	400.52M	424.93M
Balance Sheet
Total Assets	9.17B	11.41B	7.25B	6.10B	2.59B
Cash, Cash Equivalents and Short-Term Investments	2.17B	1.81B	1.65B	2.96B	1.64B
Total Debt	4.34B	5.16B	2.14B	544.39M	75.21M
Total Liabilities	7.16B	9.53B	4.54B	1.94B	1.33B
Stockholders Equity	1.41B	1.14B	2.48B	4.14B	1.27B
Cash Flow
Free Cash Flow	447.19M	-1.54B	-1.94B	-377.40M	823.99M
Operating Cash Flow	509.01M	-1.44B	-1.83B	-366.94M	830.91M
Investing Cash Flow	470.79M	-1.79B	-1.13B	-860.09M	-7.99M
Financing Cash Flow	-623.13M	3.39B	1.45B	2.56B	-93.65M

J Frontier Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1326.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Negative. The current price of 1326 is above the 20-day moving average (MA) of 1263.25, below the 50-day MA of 1336.94, and below the 200-day MA of 1594.65, indicating a bearish trend. The MACD of -24.19 indicates Negative momentum. The RSI at 44.04 is Neutral, neither overbought nor oversold. The STOCH value of 60.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2934.

J Frontier Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3902	63 Neutral	¥65.59B	228.03	―	0.39%	6.17%	-8918.66%
4483	63 Neutral	¥214.31B	26.76	―	0.43%	20.55%	48.62%
9218	52 Neutral	¥7.56B	33.39	―	―	41.16%	2750.91%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
4480	51 Neutral	¥57.19B	77.03	5.76%	―	31.95%	-40.95%
4438	50 Neutral	¥2.91B	-4.28	―	―	16.19%	-4.42%
2934	42 Neutral	¥6.69B	-12.58	―	―	11.40%	―